Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial
Open Access
- 9 January 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 24 (4), 888-895
- https://doi.org/10.1093/humrep/den475
Abstract
The aim of this study was to determine whether postal testing kits (PTKs) or patient-delivered partner therapy (PDPT) for partners of women with Chlamydia trachomatis reduce re-infection rates in women, compared with partner notification by patient referral. Three hundred and thirty women testing positive for chlamydia, at clinics for genitourinary medicine, family planning and termination of pregnancy in Edinburgh, were randomized to one of three partner interventions: patient referral, PTK (partners post urine for testing) or PDPT (1 g azithromycin for partners). Women submitted urine for chlamydia testing every 3 months. The primary outcome was re-infection assessed as time to first positive result by the Cox proportional hazard regression. The proportion of partners tested or treated with each intervention was determined. Out of 330 women, 215 (65%) were retested over 12 months. There were 32 of 215 women (15%) who retested positive (7, 15 and 10 women from the patient referral, PTK and PDPT groups, respectively). There was no significant difference in re-infection between PDPT versus patient referral (HR 1.32, 95% CI 0.50–3.56), PTK versus patient referral (HR 2.35, 95% CI 0.94–5.88) or PDPT versus PTK (HR 0.55, 95% CI 0.24–1.24). There was no significant difference in the proportion of partners confirmed tested/treated between the patient referral (34%) and PTK (41%, P = 0.32) or PDPT (42%, P = 0.28) groups. PTK and PDPT do not reduce re-infection rates in women with chlamydia compared with patient referral. However, PDPT may offer other advantages such as simplicity and cost compared with patient referral.Keywords
This publication has 18 references indexed in Scilit:
- Willingness of gynaecologists, doctors in family planning, GPs, practice nurses and pharmacists to adopt novel interventions for treating sexual partners of women with chlamydiaBJOG: An International Journal of Obstetrics and Gynaecology, 2007
- How much do delayed healthcare seeking, delayed care provision, and diversion from primary care contribute to the transmission of STIs?Sexually Transmitted Infections, 2007
- Stigma, Sexually Transmitted Infections and Attendance at the GUM ClinicJournal of Health Psychology, 2007
- Genital infection in male partners of women with chlamydial infectionInternational Journal of STD & AIDS, 2006
- Patient-Delivered Partner Treatment for Male Urethritis: A Randomized, Controlled TrialClinical Infectious Diseases, 2005
- Effect of Expedited Treatment of Sex Partners on Recurrent or Persistent Gonorrhea or Chlamydial InfectionNew England Journal of Medicine, 2005
- Sex differences in the experience of testing positive for genital chlamydia infection: a qualitative study with implications for public health and for a national screening programmeSexually Transmitted Infections, 2003
- Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis.Sexually Transmitted Infections, 1998
- Home sampling versus conventional contact tracing for detecting Chlamydia trachomatis infection in male partners of infected women: randomised studyBMJ, 1998
- Recurrent genitourinary chlamydial infections in sexually active female adolescentsThe Journal of Pediatrics, 1992